Open AccessPivotal molecules of MHC I pathway in human primary hepatocellular carcinoma
Author(s) -
Wei Chen,
Ming Cai,
Dapeng Wei,
Xia Wang
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i21.3297
Subject(s) - ctl* , hepatocellular carcinoma , major histocompatibility complex , mhc class i , immunohistochemistry , human leukocyte antigen , antigen processing , cytotoxic t cell , antigen , cancer research , immunology , medicine , biology , cd8 , in vitro , biochemistry
To investigate the expression of several important molecules involved in major histocompatibility complex (MHC) class I presentation pathway in primary hepatocellular carcinoma (HCC), and to determine whether cytotoxic T lymphocyte (CTL) vaccine therapy was suitable for HCC.